Abstract
We aimed to evaluate prevalence, phenotype, and therapeutic realities of pain in patients with Parkinson disease (PD). Therefore, we assessed 181 outpatients with PD using a cross-sectional approach applying the German Pain Questionaire (DSF), the PainDetect, and a self-developed Parkinson Disease Pain Questionaire (UPDPQ) covering detailed therapeutic aspects. Furthermore, we investigated the association between pain and PD-disease characteristics, quality of life (PDQ-39), depression, and anxiety (HADS-D, HADS-A). Overall, prevalence of pain was high (95.4%); 91.1% suffered from chronic pain, but in only 22.3% of them, pain disorder was diagnosed. Pain impaired everyday-life moderately to very severely in 48.4% of patients and was the most distressing symptom in 10.2% of all patients. Pain was localized mainly in the back (71.4%) or joints (52.4%), frequently occurred as pain attacks (79%) but appeared with neuropathic character in only 15.3% of patients. Most patients (74.2%) received some kind of pain treatment, mainly provided by orthopedists (62.0%) or general practitioners (50.0%). Physiotherapy (61.3%), pain killers (54.4%), or massage (35.5%) were the most frequent therapeutic measures. Rehabilitative therapy (96.3%) and physiotherapy (89.5%) were rated as most effective, but with vastly temporary effects. 53.3% of patients attributed PD as the main cause for their pain, but only 33.6% found relief from anti-parkinsonian drugs. High levels of pain were associated with higher scores of depression and anxiety, and lower quality of life. Results suggest that pain in PD is frequent, complex, and quality-of-life-impairing but under-diagnosed and unsystematically treated and indicate need to systematically investigate pathophysiology-based treatment strategies.
Similar content being viewed by others
References
Abrantes AM, Friedman JH, Brown RA, Strong DR, Desaulniers J, Ing E, Saritelli J, Riebe D (2012) Physical activity and neuropsychiatric symptoms of Parkinson disease. J Geriatr Psychiatry Neurol 25:138–145
Beiske AG, Loge JH, Ronningen A, Svensson E (2009) Pain in Parkinson’s disease: prevalence and characteristics. Pain 141:173–177
Berger K, Broll S, Winkelmann J, Heberlein I, Müller T, Ries V (1999) Untersuchung zur Relibilität der deutschen Version des PDQ-39. Ein krankheitsspezifischer Fragebogen zur erfassung der Lebensqualität von Parkinson-Patienten. Akt Neurol 26:180–184
Bouhassira D, Lanteri-Minet M, Attal N, Laurent B, Touboul C (2008) Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 136:380–387
Brefel-Courbon C, Payoux P, Thalamas C, Ory F, Quelven I, Chollet F, Montastruc JL, Rascol O (2005) Effect of levodopa on pain threshold in Parkinson’s disease: a clinical and positron emission tomography study. Mov Disord 20:1557–1563
Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D (2006) Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 10:287–333
Broen MP, Braaksma MM, Patijn J, Weber WE (2012) Prevalence of pain in Parkinson’s disease: a systematic review using the modified QUADAS tool. Mov Disord 27:480–484
Casser HR, Huppe M, Kohlmann T, Korb J, Lindena G, Maier C, Nagel B, Pfingsten M, Thoma R (2012) German pain questionnaire and standardised documentation with the KEDOQ-Schmerz. A way for quality management in pain therapy. Schmerz 26:168–175
Chaudhuri KR, Healy DG, Schapira AH (2006) Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol 5:235–245
Chaudhuri KR, Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, Brown RG, Koller W, Barone P, Macphee G, Kelly L, Rabey M, MacMahon D, Thomas S, Ondo W, Rye D, Forbes A, Tluk S, Dhawan V, Bowron A, Williams AJ, Olanow CW (2006) International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov Disord 21:916–923
Chaudhuri KR, Rizos A, Trenkwalder C, Rascol O, Pal S, Martino D, Carroll C, Paviour D, Falup-Pecurariu C, Kessel B, Silverdale M, Todorova A, Sauerbier A, Odin P, Antonini A, Martinez-Martin P (2015) King’s Parkinson’s disease pain scale, the first scale for pain in PD: an international validation. Mov Disord 30:1623–1631
Cleeland CS, Ryan KM (1994) Pain assessment: global use of the brief pain inventory. Ann Acad Med Singapore 23:129–138
Cury RG, Galhardoni R, Fonoff ET, Perez LS, Dos Santos Ghilardi MG, Barbosa ER, Teixeira MJ, Ciampi DA (2016) Sensory abnormalities and pain in Parkinson disease and its modulation by treatment of motor symptoms. Eur J Pain 20:151–165
Fincham JE (2008) Response rates and responsiveness for surveys, standards, and the Journal. Am J Pharm Educ 72:43
Ford B (1998) Pain in Parkinson’s disease. Clin Neurosci 5:63–72
Freynhagen R, Baron R, Gockel U, Tolle TR (2006) painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin 22:1911–1920
Gerdelat-Mas A, Simonetta-Moreau M, Thalamas C, Ory-Magne F, Slaoui T, Rascol O, Brefel-Courbon C (2007) Levodopa raises objective pain threshold in Parkinson’s disease: a RIII reflex study. J Neurol Neurosurg Psychiatry 78:1140–1142
Grashorn W, Schunke O, Buhmann C, Forkmann K, Diedrich S, Wesemann K, Bingel U (2015) Influence of dopaminergic medication on conditioned pain modulation in Parkinson’s disease patients. PLoS One 10:e0135287
Herrmann C (1997) International experiences with the Hospital Anxiety and Depression Scale—a review of validation data and clinical results. J Psychosom Res 42:17–41
Herrmann C, Buss U, Snaith RP (1995) HADS-D: Hospital Anxiety and Depression Scale-Deutsche Version; ein Fragebogen zur Erfassung von Angst und Depressivität in der somatischen Medizin. Verlag Hans Huber, Bern, Schweiz
Hoehn MM (1987) Parkinson’s disease: progression and mortality. Adv Neurol 45:457–461
Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184
Keller T, Freynhagen R, Tolle TR, Liwowsky I, Moller P, Hullemann P, Gockel U, Stemmler E, Baron R (2016) A retrospective analysis of the long-term test-retest stability of pain descriptors of the painDETECT questionnaire. Curr Med Res Opin 32:343–349
Lee MA, Walker RW, Hildreth TJ, Prentice WM (2006) A survey of pain in idiopathic Parkinson’s disease. J Pain Symptom Manage 32:462–469
Loprinzi PD, Herod SM, Cardinal BJ, Noakes TD (2013) Physical activity and the brain: a review of this dynamic, bi-directional relationship. Brain Res 1539:95–104
Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, Macphee G, Brown RG, Naidu Y, Clayton L, Abe K, Tsuboi Y, MacMahon D, Barone P, Rabey M, Bonuccelli U, Forbes A, Breen K, Tluk S, Olanow CW, Thomas S, Rye D, Hand A, Williams AJ, Ondo W, Chaudhuri KR (2007) Prevalence of nonmotor symptoms in Parkinson’s disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 22:1623–1629
Mylius V, Pee S, Pape H, Teepker M, Stamelou M, Eggert K, Lefaucheur JP, Oertel WH, Moller JC (2016) Experimental pain sensitivity in multiple system atrophy and Parkinson’s disease at an early stage. Eur J Pain 20:1223–1228
Nagel B, Gerbershagen HU, Lindena G, Pfingsten M (2002) Development and evaluation of the multidimensional German pain questionnaire. Schmerz 16:263–270
Negre-Pages L, Regragui W, Bouhassira D, Grandjean H, Rascol O (2008) Chronic pain in Parkinson’s disease: the cross-sectional French DoPaMiP survey. Mov Disord 23:1361–1369
Quinn NP, Koller WC, Lang AE, Marsden CD (1986) Painful Parkinson’s disease. Lancet 1:1366–1369
Quittenbaum BH, Grahn B (2004) Quality of life and pain in Parkinson’s disease: a controlled cross-sectional study. Parkinsonism Relat Disord 10:129–136
Rana AQ, Kabir A, Jesudasan M, Siddiqui I, Khondker S (2013) Pain in Parkinson’s disease: analysis and literature review. Clin Neurol Neurosurg 115:2313–2317
Riedel O, Klotsche J, Spottke A, Deuschl G, Forstl H, Henn F, Heuser I, Oertel W, Reichmann H, Riederer P, Trenkwalder C, Dodel R, Wittchen HU (2010) Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson’s disease. J Neurol 257:1073–1082
Schrag A, Jahanshahi M, Quinn N (2000) How does Parkinson’s disease affect quality of life? A comparison with quality of life in the general population. Mov Disord 15:1112–1118
Starkstein SE, Preziosi TJ, Robinson RG (1991) Sleep disorders, pain, and depression in Parkinson’s disease. Eur Neurol 31:352–355
Tait RC, Pollard CA, Margolis RB, Duckro PN, Krause SJ (1987) The Pain Disability Index: psychometric and validity data. Arch Phys Med Rehabil 68:438–441
Valkovic P, Minar M, Singliarova H, Harsany J, Hanakova M, Martinkova J, Benetin J (2015) Pain in Parkinson’s disease: a cross-sectional study of its prevalence, types, and relationship to depression and quality of life. PLoS One 10:e0136541
van Nimwegen M, Speelman AD, Smulders K, Overeem S, Borm GF, Backx FJ, Bloem BR, Munneke M (2010) Design and baseline characteristics of the ParkFit study, a randomized controlled trial evaluating the effectiveness of a multifaceted behavioral program to increase physical activity in Parkinson patients. BMC Neurol 10:70
Ware J Jr, Kosinski M, Keller SD (1996) A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 34:220–233
Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483
Wasner G, Deuschl G (2006) Chapter 50 Pain in Parkinson’s disease. Handb Clin Neurol 81:747–760
Wasner G, Deuschl G (2012) Pains in Parkinson disease–many syndromes under one umbrella. Nat Rev Neurol 8:284–294
Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Financial disclosure/conflict of interest concerning the research related to the manuscript
None.
Study funding
This work was supported by grants from the German Research Foundation (SFB936/1[UB]), the German Parkinson Foundation (Deutsche Parkinson Vereinigung (dpv) e.V. [WG, CB, UB]), and the LIIRA Grant by Pfizer (UB). The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Conflicts of interest
C Buhmann has received grants from the German Parkinson foundation (=Deutsche Parkinsonvereinigung dPV e.V.) and the Georg & Jürgen Rickertsen Stiftung Hamburg; he has received honoraria as speaker and scientific advisory board member from UCB and Zambon during the conduct of the study. Ulrike Bingel received grants from the dPV, BMBF (FK01GQ0808), Pfizer (LIIRA), German Research Foundation (SFB936), and received honoraria as a speaker from Grünenthal, Teva, Bionorica, Ipsen, Boehringer Ingelheim, and Allergan during the conduct of the study. Wiebke Grashorn received a grant from the dPV during the conduct of the study. N. Wrobel, O. Fruendt, K. Wesemann, and S. Dietrich have nothing to disclose.
Rights and permissions
About this article
Cite this article
Buhmann, C., Wrobel, N., Grashorn, W. et al. Pain in Parkinson disease: a cross-sectional survey of its prevalence, specifics, and therapy. J Neurol 264, 758–769 (2017). https://doi.org/10.1007/s00415-017-8426-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-017-8426-y